Karin Fijnvandraat

MD PhD
Department of Pediatric Hematology, Amsterdam UMC, University of Amsterdam, Emma Children’s Hospital, Amsterdam, The Netherlands

Presentation(s):

• PB0185 - Exploring red blood cells as a novel tolerogenic approach for factor VIII inhibitors employing immuno-dominant FVIII derived peptides presented on MHC class II

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• OC 37.5 - Liver sinusoidal endothelial cells as a novel target for tolerance induction to FVIII

  Monday, July 11, 2022
  11:45 AM – 12:00 PM